相关实验视频

Updated: Jun 3, 2025

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Near Infrared Photoimmunotherapy for Mouse Models of Pleural Dissemination

Published on: February 9, 2021

一个干扰线粒体的纳米复合体与光动力疗法合作,以提高抗瘤免疫力

Zhijie Zhang¹, Qingfu Zhao¹, Qingqing Xu¹

¹National Engineering Research Center for Nanomedicine, College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, PR China.

|January 12, 2025

概括

这项研究引入了一种新的纳米粒子疗法,可以增强免疫系统.

科学领域:

纳米医学和癌症免疫疗法
生物材料和药物输送

背景情况:

三阴性乳腺癌 (TNBC) 是一种具有有限治疗选择的侵袭性亚型.
目前针对TNBC的免疫疗法因免疫抑制瘤微环境而面临挑战.
编程细胞死亡配体1 (PD-L1) 是一个关键的免疫检查点,促进瘤免疫逃避.

研究的目的:

开发TNBC的组合疗法,同时增加瘤免疫性并降低PD-L1.1的调节.
增强抗瘤免疫力,克服TNBC中免疫抑制性瘤微环境.
研究一种新型纳米粒子配方对协同治疗效果的潜力.

主要方法:

通过一式水性方法合成 bis ((diethyldithiocarbamate) -copper/indocyanine绿色纳米颗粒 (CuET/ICG NP).
使用CuET/ICGNP诱导免疫细胞死亡 (ICD) 通过光动力学疗法 (PDT) 通过干扰线粒体和缓解瘤缺氧.
在低氧条件下研究AMP激活蛋白激酶 (AMPK) 介导的膜PD-L1 (mPD-L1) 在癌细胞和癌症干细胞 (CSC) 中下调的途径.

主要成果:

CuET/ICG NPs有效地强化了PDT,导致扩大了ICD和增加了瘤免疫性.
由NP诱导的线粒体功能障碍激活了AMPK通路,导致mPD-L1表达的减少.
组合疗法表现出协同效应,激活抗瘤免疫力,并建立长期的免疫记忆,防止瘤再次挑战.

结论:

开发的CuET/ICGNP为TNBC的联合治疗提供了一个有前途的战略.
这种方法有效地重新编程瘤微环境,增强对TNBC的免疫反应.
这项研究强调了简单的生物医学材料和多模式治疗的潜力,以克服瘤免疫抑制.

关键词:

这就是AMPKK.在CSCs的CSCs.氧气过低是因为缺氧.免疫治疗药物免疫治疗药物线粒体中的线粒体.在PD-L1中.

更多相关视频

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy

Published on: May 22, 2020

相关概念视频

Electron Transport Chain: Complex I and II

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.